What makes the host-parasite relationship so special? How have obligate parasites evolved to survive and thrive within the hosts they have chosen? What is it about host cells that the parasites can’t live without, and how might host cells respond in return? The Epi-Api lab at GIMM is interested in answering these questions, and more, initially through the twin lenses of the intestinal parasite Cryptosporidium (‘Crypto’) and the intestinal epithelial cell. This ‘twin-lens’ approach enables us to uniquely frame and capture the cell biological, immunological, and evolutionary host-parasite relationship with a sharp yet dynamic focus.
Crypto is in the same family of deadly apicomplexan parasites such as Plasmodium and Toxoplasma. However, unlike its relatives, Crypto only infects epithelial cells, completing its full life cycle in one host. No stranger to disease, it is one of the leading causes of diarrheal disease and deaths in young children worldwide. It also plagues people with suppressed immune systems, and the livestock industry. There is no vaccine or effective treatment for Cryptosporidiosis in humans.
We are interested in studying Crypto not only to potentially find better therapies, but also to better understand fundamental host and apicomplexan cell biologies. We are also interested in understanding the host immune response to Crypto infections, particularly the role of certain immune cell types that we know are important to fight Crypto infections in mice and humans. We believe this is crucial to developing effective treatments and vaccines against this deadly disease.
Marzook, N.B., Song, O., Baumgärtel, L., Bernitz, N., Mkandawire, T., Watson, L. C., Nunes, V., Macrae, J., Warchal, S., Howell, M., Sateriale, A. (2025) The essential host genome for Cryptosporidium intracellular survival reveals metabolic dependencies that can be leveraged for treatment. Cell 188 (21) pp. 5947-5961 PMID: 40706591, DOI: 10.1016/j.cell.2025.07.001.
Rodrigues, E.*, Marzook, N.B.*, Pallett, M.A.*, Sateriale, A.* (2025) Convergent mechanisms of epithelial cell structure manipulation by intestinal pathogens. PLOS Pathogens 21(7): e1013367, PMID: 40743117. DOI: 10.1371/journal.ppat.1013367. (* co-authors)
Watson, L. C., Sala, K.A., Bernitz, N., Baumgärtel, L, Pallett, M.A., Marzook, N.B., Straker, L.C., Peng, D., Collinson, L., Sateriale, A. (2025) Targeted CRISPR screens reveal genes essential for Cryptosporidium survival in the host intestine. Nature Communications 16, 7749 DOI: 10.1038/s41467-025-63012-1; PMID 40835841.
Warchal, S., Song, O., Instrell, R., Marzook, B., Jiang, M., Queval, C., Tuersley, J., Saville, H., Sateriale, A., Howell, M. (2025) Key Considerations Before Embarking on an HCS Screening Campaign; in High Content Imaging in Drug Discovery, ed. J. Pilling and N. Carragher, Royal Society of Chemistry, 2025, 86, ch. 1, pp. 1-25, DOI: 10.1039/9781837676941-00001.
Maradana, M. R. *, Marzook, N. B.*, Diaz, O. E., Mkandawire, T., Diny, N. L., Li, Y., Liebert, A., Shah, K, Tolaini, M., Kváč, M., Stockinger, B., Sateriale, A. (2023) Dietary environmental factors shape the immune defence against Cryptosporidium infection. Cell Host & Microbe 31 (12) pp. 2038-2050, PMID 38052207, DOI: 10.1016/j.chom.2023.11.008 (* co-authors).
Marzook, N. B. and Sateriale, A. (2020) Crypto-currency: Investing in new models to advance the study of Cryptosporidium immunity and infection. Front Cell Infect Microbiol 10: 587296, PMID 33312965, DOI: 10.3389/fcimb.2020.587296.
On the Verge of Discovery